Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Calhoun

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Mutation|March 26, 2003
A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766TPaula M Hempen, Harsha Kurpad, Eric S Calhoun, et al.
Biotechniques|November 3, 2004
Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive mediaJonathan R Brody, Eric S Calhoun, Eike Gallmeier, et al.
Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.
Gynecologic Oncology|December 8, 2004
Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervixStephen A Contag, Bobbie S Gostout, Amy C Clayton, et al.
Cancer Biology & Therapy|March 28, 2007
Gene-specific selection against experimental fanconi anemia gene inactivation in human cancerEike Gallmeier, Tomas Hucl, Eric S Calhoun, et al.
Cancer Research|June 3, 2006
Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor lossSteven C Cunningham, Eike Gallmeier, Tomas Hucl, et al.
Clinical Chemistry|July 27, 2002
Host genetic polymorphism analysis in cervical cancerEric S Calhoun, Renee M McGovern, Carol A Janney, et al.
Gastroenterology|June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic optionsEike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Cancer Research|August 17, 2006
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arraysEric S Calhoun, Tomas Hucl, Eike Gallmeier, et al.
Gynecologic Oncology|March 22, 2003
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer riskBobbie S Gostout, Gregory A Poland, Eric S Calhoun, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Mutation|March 26, 2003
A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766TPaula M Hempen, Harsha Kurpad, Eric S Calhoun, et al.
Biotechniques|November 3, 2004
Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive mediaJonathan R Brody, Eric S Calhoun, Eike Gallmeier, et al.
Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.
Gynecologic Oncology|December 8, 2004
Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervixStephen A Contag, Bobbie S Gostout, Amy C Clayton, et al.
Cancer Biology & Therapy|March 28, 2007
Gene-specific selection against experimental fanconi anemia gene inactivation in human cancerEike Gallmeier, Tomas Hucl, Eric S Calhoun, et al.
Cancer Research|June 3, 2006
Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor lossSteven C Cunningham, Eike Gallmeier, Tomas Hucl, et al.
Clinical Chemistry|July 27, 2002
Host genetic polymorphism analysis in cervical cancerEric S Calhoun, Renee M McGovern, Carol A Janney, et al.
Gastroenterology|June 10, 2006
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic optionsEike Gallmeier, Eric S Calhoun, Carlo Rago, et al.
Cancer Research|August 17, 2006
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arraysEric S Calhoun, Tomas Hucl, Eike Gallmeier, et al.
Gynecologic Oncology|March 22, 2003
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer riskBobbie S Gostout, Gregory A Poland, Eric S Calhoun, et al.
Pageof 2